Skip to content

Clinical trials to evaluate the effectiveness of lingonberry and amla fruit extract intake

Clinical trials to evaluate the effectiveness of lingonberry and amla fruit extract intake - Clinical trials to evaluate the effectiveness of lingonberry and amla fruit extract intake

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031682
Enrollment
90
Registered
2018-03-14
Start date
2015-11-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The healthy female who feels decline of the skin condition

Interventions

In the placebo group, the placebo drink must take in every day for 12 weeks. The placebo beverage is prepared with the same amounts of sweetener, sour seasoning and flavor as test beverage, so tha
the lingonberry and amla fruit extract (LAE) single dose drink&quot
must take in every day for 12 weeks. The test beverage of &quot
LAE double dose drink&quot
must take in every day for 12 weeks.

Sponsors

SHISEIDO CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Healthy females from 35 years old to 50 years old 2.Individuals conscious of skin roughness by drying 3.Individuals who has felt an effect on skin by the intake of the supplement 4.Individuals who feels a decrease of the elasticity of the skin 5. Individuals who does not use a supplement and a drug regularly now 6. Individuals who abstain from drinking alcohol from the day before measurement to the measurement end 7. Individuals who agree to participate in the study 8. Individuals judged appropriate for the study by attendant physician

Exclusion criteria

Exclusion criteria: 1.Individuals with abnormalities of skin areas planned to be tested 2.Individuals considered likely to develop allergy to the test substance (Individuals with food allergy) 3.Individuals with chronic cutis symptoms such as atopic dermatitis 4.Patients receiving drug therapy as outpatients 5.Individuals participating in other studies within the past 3 months 6.Habitual smokers 7.Patients with asthma 8.Pregnant women, women desiring to become pregnant, or lactating women 9.Individuals having used cosmetics or the like possessing moisture-retaining effects on the skin areas planned to be tested in this study within 1 month before the start of the study 10.Individuals taking or intending to take drugs against pollinosis 11.Individuals judged inappropriate for the study by attending physician

Design outcomes

Primary

MeasureTime frame
The elasticity of the skin is measured four times for 12 weeks every four weeks.

Secondary

MeasureTime frame
The following measurement item is measured four times for 12 weeks every four weeks. 1. Skin thickness 2. Stratum corneum hydration 3. Epidermal and dermal hydration 4. Clinical evaluation of wrinkle

Countries

Japan

Contacts

Public ContactKazunori Takashima

Inforward, Inc Ebisu Skin Research Center

takashima@inforward.co.jp03-5447-6411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026